Vitiligo in a patient receiving infliximab for chronic plaque psoriasis

被引：6
作者：
Lu, Xiya [1 ]
Gao, Yunlu [1 ]
Ding, Yangfeng [1 ]
机构：
[1] Shanghai Skin Dis Hosp, Dept Dermatol, 1278 Baode Rd, Shanghai 200443, Peoples R China
来源：
DERMATOLOGIC THERAPY | 2019年 / 32卷 / 03期
关键词：
psoriasis; tumor necrosis factor-alpha; vitiligo; NECROSIS-FACTOR-ALPHA;
D O I：
10.1111/dth.12917
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
Infliximab is a tumor necrosis factor-alpha (TNF-a) inhibitor widely used in the treatment of moderate to severe chronic plaque psoriasis. Here, we report a case of vitiligo following infliximab administration in a patient with chronic plaque psoriasis. The case serves as a reminder of vitiligo induced by TNF-a-antagonist therapy.
引用
收藏
页数：3
相关论文
共 8 条
  • [1] Tumor necrosis factor-α in vitiligo: direct correlation between tissue levels and clinical parameters
    Kim, Nancy H.
    Torchia, Daniele
    Rouhani, Panta
    Roberts, Brenda
    Romanelli, Paolo
    [J]. CUTANEOUS AND OCULAR TOXICOLOGY, 2011, 30 (03) : 225 - 227
  • [2] New-onset vitiligo and progression of pre-existing vitiligo during treatment with biological agents in chronic inflammatory diseases
    Mery-Bossard, L.
    Bagny, K.
    Chaby, G.
    Khemis, A.
    Maccari, F.
    Marotte, H.
    Perrot, J. L.
    Reguiai, Z.
    Sigal, M. L.
    Avenel-Audran, M.
    Boye, T.
    Grasland, A.
    Gillard, J.
    Jullien, D.
    Toussirot, E.
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2017, 31 (01) : 181 - 186
  • [3] Inflammatory memory sensitizes skin epithelial stem cells to tissue damage (vol 550, pg 475, 2017)
    Naik, Shruti
    Larsen, Samantha B.
    Gomez, Nicholas C.
    Alaverdyan, Kirill
    Sendoel, Ataman
    Yuan, Shaopeng
    Polak, Lisa
    Kulukian, Anita
    Chai, Sophia
    Fuchs, Elaine
    [J]. NATURE, 2018, 560 (7716) : E2 - E2
  • [4] Skin Manifestations Induced by TNF-Alpha Inhibitors in Juvenile Idiopathic Arthritis
    Pontikaki, Irene
    Shahi, Edit
    Frasin, Lucretia Adina
    Gianotti, Raffaele
    Gelmetti, Carlo
    Gerloni, Valeria
    Meroni, Pier Luigi
    [J]. CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY, 2012, 42 (02) : 131 - 134
  • [5] Infliximab-induced vitiligo
    Ramírez-Hernández, M
    Marras, C
    Martínez-Escribano, JA
    [J]. DERMATOLOGY, 2005, 210 (01) : 79 - 80
  • [6] A Type II Segmental Vitiligo Developed under Infliximab Treatment for Ulcerative Colitis
    Ryu, Tae Hyung
    Lee, Dong Won
    Choi, Jae Eun
    Ahn, Hyo Hyun
    Kye, Young Chul
    Seo, Soo Hong
    [J]. ANNALS OF DERMATOLOGY, 2017, 29 (06) : 826 - 827
  • [7] Su Chinyu G, 2003, Gastroenterology, V125, P1544, DOI 10.1016/j.gastro.2003.05.009
  • [8] Tumour necrosis factor-α inhibition can stabilize disease in progressive vitiligo
    Webb, K. C.
    Tung, R.
    Winterfield, L. S.
    Gottlieb, A. B.
    Eby, J. M.
    Henning, S. W.
    Le Poole, I. C.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2015, 173 (03) : 641 - 650
1